Arkolith/Insider Trading/HRMY/Form 4

Serafin Andrew

CHIEF STRATEGY OFFICERHarmony Biosciences Holdings, Inc. (HRMY) · full profile →Form 4 · filed Jan 26, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
4 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 25, 2026Option exercise(M)3K—$03K
Jan 25, 2026Tax withholding(F)1K$36.82$41K1K
Jan 24, 2026Option exercise(M)3K—$03K
Jan 24, 2026Tax withholding(F)1K$36.82$41K1K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 25, 2026Option exercise(M)3K—$08K
Jan 24, 2026Option exercise(M)3K—$05K
Jan 22, 2026Grant(A)43K—$043K
Jan 22, 2026Grant(A)12K—$012K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001821460-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML